15.03.2012 01:20 Uhr, Quelle: Wallstreet online

Inovelon® (rufinamide) Drinkable Suspension Formulation Launched for the First Time in Europe

HATFIELD, England, March 15, 2012 /PRNewswire/ Child friendly formulation set to aid administration for the treatment of Lennox-Gastaut syndrome for patients in Germany Eisai Europe Limited today announced the launch of Inovelon(R) …

Weiterlesen bei Wallstreet online